In an article on a ketamine nasal spray recently approved to treat depression, Bita Moghaddam, Ph.D., who discovered the drug’s glutamate-reviving effect on rats, says the out-of-body experience some people experience may occur because the rapid release of glutamate “excites the heck out of a whole bunch of neurons.

Researchers at UC San Diego collaborated with Gordon Mills, M.D., Ph.D., to analyze a database of tumor protein data in a newly published study regarding two enzymes linked to pancreatic cancer survival.

In a Parents.com news series, Maureen Baldwin, M.D., discusses hCG levels and their relation to pregnancy health, miscarriage, and the chance of conceiving twins.

In a video interview filmed during the Endocrine Society’s national conference, Maria Fleseriu, M.D., says successful pregnancies are possible for women with hypopituitarism.

The Kiwanians publish a letter to the editor in support of their pediatric cancer fellowship at Doernbecher.

Nature News reports that many U.S. universities are failing to publish results of clinical trials within a year, as required by law; Erick Turner, M.D., says, “People participate in trials on the understanding that their data will be made available to benefit society and humanity at large, so failing to publish it is a violation of that.”

In an article on the popularity of cannabidiol, Kimberly Mauer, M.D., says she has seen an uptick in patients who say they are taking CBD, and their experiences are mixed: “About half the patients say they get some benefit, and about half say they didn’t notice anything.”

Cambia Grove announces its TRAILS competition to healthcare startup companies; winners will hear product feedback from representatives from OHSU Doernbecher, Children’s Hospital Los Angeles and Seattle Children’s.

Nathan Selden, M.D., Ph.D., co-authors updated a set of guidelines for the treatment of children with serious brain injury.

New research suggests adults who are regular drinkers and have had persistent atrial fibrillation may cut their chances of a recurrence by almost half if they stop drinking, or at least substantially lower their alcohol intake; P. Bart Duell, M.D., says: “ … in some ways, one of the most remarkable findings is that you had an abstinence rate of 61%. So the question is, how did you do that?"